A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Clinical trial NCT06164730 · RECRUITING

Trial details

NCT number: NCT06164730
Sponsor: Verve Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Heterozygous Familial Hypercholesterolemia Premature Coronary Heart Disease

Start date: 2024-04-30
Primary completion: 2026-08-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.